Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action- |
Mechanism MFSD8 gene transference(Major facilitator superfamily domain-containing protein 8 gene transference) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuronal Ceroid-Lipofuscinoses | Preclinical | United States | 04 May 2021 | |
Neuronal Ceroid-Lipofuscinoses | Preclinical | United States | 04 May 2021 | |
Lysosomal Storage Diseases | Preclinical | United States | - | |
Lysosomal Storage Diseases | Preclinical | United States | - |